Navigation Links
Amylin Pharmaceuticals to Present at Piper Jaffray Europe Conference
Date:6/17/2009

SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Piper Jaffray Europe Conference in London on Wednesday, June 24, 2009 at 10:30 a.m. British Summer Time/ 5:30 a.m. ET. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview.

The live presentation and breakout session will be webcast, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate Web site, located at www.amylin.com. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California. Further information about Amylin Pharmaceuticals is available at www.amylin.com.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amylin Pharmaceuticals to Webcast First Quarter Results
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2014)... Sept. 26, 2014 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic stem cell ... will hold its 2014 annual general meeting of shareholders at its ... China Tower, 1 Garden Road, Central, Hong Kong ... (8:00 a.m. U.S. Eastern Time on December 11, 2014). ...
(Date:9/26/2014)... September 26, 2014 Molecular Biology ... the cell for the regulation of cellular activity and ... interactions between genes and with its environment within the ... of new and novel therapeutic methodologies for the diagnosis, ... , On this occasion, Dr. Srinubabu Gedela, MD of ...
(Date:9/26/2014)... “Inflamax’s Clinical Data Management group is a ... this allows us to support our group in maintaining ... Johnson, Director of Data Management at Inflamax. “Being ... our Clinical Data Managers have been certified by passing ... to offering only the best services to our clients, ...
(Date:9/25/2014)... implicated in several cancers appears to play a pivotal role ... to a new study by NYU Langone Medical Center scientists. ... . , Stem cells are the perpetual adolescents of the ... can be programmed to differentiate into any mature cell type, ... understanding of their biology, however, is needed. ...
Breaking Biology Technology:China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 11, 2014 2Understanding Genetics and Molecular Biology to Avert Dreadful Medical Challenges during Open Access Week 2Understanding Genetics and Molecular Biology to Avert Dreadful Medical Challenges during Open Access Week 3NYU Langone scientists identify key factor that maintains stem cell identity 2
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) ... research group at The Institute of Cancer Research, ... combination treatment schedules,of reovirus and radiation in human ... The paper, entitled "Enhanced In vitro and In ...
... environment and holding it indefinitely in molecular-sized containers has been ... say it represents a novel method of gas storage that ... safely and efficiently. , This is a proof of concept ... just improving on a method that already exists, said U ...
... the economy is not,only heading towards a recession but ... during January. However, biotech held steady,with the Burrill Biotech ... posted a January loss of 9.9%, and the Dow, ... ride out extremely volatile capital,markets with less damage because ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy 2Rounding up gases, nano-style 2January Market Jitters Fails to Derail Biotech 2January Market Jitters Fails to Derail Biotech 3January Market Jitters Fails to Derail Biotech 4
(Date:9/29/2014)... Advocacy Awards will honor ... medical progress to improve the health and economic ... place on Wednesday, March 11, 2015, at the ... The 2015 Advocacy Award winners are ABC,s "Good ... of the Milken Institute and FasterCures; Dr. Kenneth ...
(Date:9/29/2014)... Energy Joint Genome Institute (DOE JGI), a DOE ... 32 new projects have been selected for the ... lakes to Caribbean waters, and from plant root ... in forested watersheds, the CSP 2015 projects portfolio ... be extracted. , "These projects catalyze JGI,s ...
(Date:9/29/2014)... WASHINGTON, Sept. 29, 2014 Oktoberfest is ... nothing worse than reaching for a cold ... your beer,s been skunked: chemicals have reacted ... bitter taste. This week, Reactions explains why ... do to keep your brews from going ...
Breaking Biology News(10 mins):Research!America to honor leaders in medical and health research advocacy 2Research!America to honor leaders in medical and health research advocacy 3Research!America to honor leaders in medical and health research advocacy 42015 DOE JGI's science portfolio delves deeper into the Earth's data mine 22015 DOE JGI's science portfolio delves deeper into the Earth's data mine 32015 DOE JGI's science portfolio delves deeper into the Earth's data mine 42015 DOE JGI's science portfolio delves deeper into the Earth's data mine 52015 DOE JGI's science portfolio delves deeper into the Earth's data mine 62015 DOE JGI's science portfolio delves deeper into the Earth's data mine 72015 DOE JGI's science portfolio delves deeper into the Earth's data mine 82015 DOE JGI's science portfolio delves deeper into the Earth's data mine 9
... by the University of Zaragoza (UNIZAR) started to carry out ... then they have focused on analysing the fossil remains of ... the Cantabrian region over the past 41,000 years, at the ... conservation status of the fossils have enabled the researchers to ...
... in <A HREF=",http://chinese.eurekalert.org/zh/emb_releases/2009-06/kcl-nss060209.php,">Chinese . Flooding is ... globe. It is the worst natural disaster in the ... figure is expected to increase to 3.5 billion over ... that took place in China over the past decade ...
... In recent years, obesity has taken on epidemic proportions ... early death and rising health care costs. According to ... a quarter of all American adults and more than ... While recent research advances and treatment ...
Cached Biology News:Cantabrian cornice has experienced seven cooling and warming phases over past 41,000 years 2Next-generation software system for flood warning and risk analysis to be developed 2Researchers engineer metabolic pathway in mice to prevent diet-induced obesity 2Researchers engineer metabolic pathway in mice to prevent diet-induced obesity 3
... new MALDI O-TOF creates a new category ... orthogonal platform that has been licensed to ... of Manitoba. , As the first single ... and collisional cooling, the prOTOF 2000 represents ...
Rat Dermal Fibroblasts (RDF) (>500,000 cells)...
...
... The NeuroLog System is a compact, versatile & ... variety of purposes including: Intracellular, Extracellular, Transducer ... The NeuroLog Case & Power Supply unit ... Modules are not only powered by this ...
Biology Products: